For: | Chaiteerakij R, Pan-ngum W, Poovorawan K, Soonthornworasiri N, Treeprasertsuk S, Phaosawasdi K. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study. World J Gastroenterol 2017; 23(39): 7160-7167 [PMID: 29093624 DOI: 10.3748/wjg.v23.i39.7160] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i39/7160.htm |
Number | Citing Articles |
1 |
Roongruedee Chaiteerakij. Diagnosis and Management of Cholangiocarcinoma. 2021; : 137 doi: 10.1007/978-3-030-70936-5_5
|
2 |
Riham Katkhuda, Yun Shin Chun. Intrahepatic Cholangiocarcinoma. 2019; : 1 doi: 10.1007/978-3-030-22258-1_1
|
3 |
Kavin Thinkhamrop, Narong Khuntikeo, Nittaya Chamadol, Apiporn T. Suwannatrai, Surachai Phimha, Matthew Kelly. Associations between ultrasound screening findings and cholangiocarcinoma diagnosis in an at-risk population. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17794-9
|
4 |
Phonpilas Thongpon, Kitti Intuyod, Sasitorn Chomwong, Thatsanapong Pongking, Sirinapha Klungsaeng, Kanha Muisuk, Naruechar Charoenram, Chutima Sitthirach, Raynoo Thanan, Porntip Pinlaor, Somchai Pinlaor. Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66945-7
|
5 |
Chi-Chih Wang, Ming-Hseng Tseng, Sheng-Wen Wu, Tzu-Wei Yang, Hsuan-Yi Chen, Wen-Wei Sung, Chang-Cheng Su, Yao-Tung Wang, Chun-Che Lin, Ming-Chang Tsai. Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention. World Journal of Gastrointestinal Oncology 2020; 12(12): 1381-1393 doi: 10.4251/wjgo.v12.i12.1381
|
6 |
Paiboon Sithithaworn, Ross H. Andrews, Viatcheslav A. Mordvinov, Maria Y. Pakharukova, Maria N. Lvova. Encyclopedia of Food Safety. 2024; : 673 doi: 10.1016/B978-0-12-822521-9.00068-X
|
7 |
Aumkhae Sookprasert, Kosin Wirasorn, Jarin Chindaprasirt, Piyakarn Watcharenwong, Thanachai Sanlung, Siraphong Putraveephong. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research 2023; 219: 223 doi: 10.1007/978-3-031-35166-2_8
|
8 |
Dong Woo Shin, Sung-Hoon Moon, Jong Hyeok Kim. Diagnosis of Cholangiocarcinoma. Diagnostics 2023; 13(2): 233 doi: 10.3390/diagnostics13020233
|
9 |
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 2020; 126(11): 2666 doi: 10.1002/cncr.32803
|
10 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 291 doi: 10.1002/9781119756422.ch17
|
11 |
Apiporn T. Suwannatrai, Kavin Thinkhamrop, Archie C. A. Clements, Matthew Kelly, Kulwadee Suwannatrai, Bandit Thinkhamrop, Narong Khuntikeo, Darren J. Gray, Kinley Wangdi. Bayesian spatial analysis of cholangiocarcinoma in Northeast Thailand. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50476-7
|
12 |
Thiyaphat Laohawetwanit, Naruemon Klaikaew. Pathological aspects of mucinous cholangiocarcinoma: A single‐center experience and systematic review. Pathology International 2020; 70(9): 661 doi: 10.1111/pin.12983
|
13 |
Simona Tavolari, Giovanni Brandi. Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review. Cells 2023; 12(9): 1216 doi: 10.3390/cells12091216
|
14 |
Yu-Chan Chang, Ming-Huang Chen, Chun-Nan Yeh, Michael Hsiao. Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma. Biomolecules 2020; 10(10): 1377 doi: 10.3390/biom10101377
|
15 |
Kavin Thinkhamrop, Narong Khuntikeo, Wongsa Laohasiriwong, Pornpimon Chupanit, Matthew Kelly, Apiporn T. Suwannatrai, Sutas Suttiprapa. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand. PLOS Neglected Tropical Diseases 2021; 15(9): e0009741 doi: 10.1371/journal.pntd.0009741
|
16 |
Gyokukou You, Lu Zeng, Hideaki Tanaka, Emi Ohta, Takahiro Fujii, Kazuhiko Ohshima, Masakazu Tanaka, Nobuyuki Hamajima, Chutiwan Viwatthanasittiphong, Mantana Muangphot, Dhiraphol Chenvidhya, Adisorn Jedpiyawongse, Banchob Sripa, Masanao Miwa, Satoshi Honjo. Polymorphism of genes encoding drug-metabolizing and inflammation-related enzymes for susceptibility to cholangiocarcinoma in Thailand. World Journal of Gastrointestinal Pathophysiology 2023; 14(2): 21-33 doi: 10.4291/wjgp.v14.i2.21
Abstract(371) |
Core Tip(361) |
Full Article(HTML)(1367)
|
Full Article (PDF)-646K(122)
|
Full Article (Word)-163K(32)
|
Audio-4013K(3)
|
Peer-Review Report-228K(50)
|
Answering Reviewers-130K(50)
|
Times Cited (0)
|
Total Visits (5130)
|
Open
|
17 |
Charupong Saengboonmee, Wunchana Seubwai, Worachart Lert-itthiporn, Thanachai Sanlung, Sopit Wongkham. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication. Canadian Journal of Diabetes 2021; 45(3): 282 doi: 10.1016/j.jcjd.2020.09.008
|
18 |
Achirawit Surapinit, Apisit Chaidee, Somchai Pinlaor, Suppakrit Kongsintaweesuk, Naruechar Charoenram, Narumon Mahaamnad, Chadamas Sakonsinsiri, Nuttanan Hongsrichan. Atrazine promotes cholangiocarcinoma cell proliferation and migration via GPER-mediated PI3K/Akt/NF-κB pathway. Pesticide Biochemistry and Physiology 2024; 203: 105988 doi: 10.1016/j.pestbp.2024.105988
|
19 |
Kavin Thinkhamrop, Kulwadee Suwannatrai, Matthew Kelly, Apiporn T. Suwannatrai. Spatial analysis of cholangiocarcinoma in relation to diabetes mellitus and Opisthorchis viverrini infection in Northeast Thailand. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61282-1
|